Latest Share Purchase Plans News

Catapult Sports has successfully completed a A$130 million institutional placement to fund its strategic acquisition of IMPECT GmbH, a leader in soccer analytics software. The company also launched a A$20 million Share Purchase Plan to engage existing shareholders.

Paladin Energy reported a record uranium production quarter at its Langer Heinrich Mine alongside a successful A$300 million equity raise, positioning the company for accelerated development of its Patterson Lake South project.

Canterbury Resources is on the cusp of completing a pivotal scoping study for its Briggs Copper Project, while deep drilling advances to unlock higher-grade mineralisation. The company also moves forward with new exploration initiatives and a share purchase plan to bolster funding.

INOVIQ Limited has launched an A$11.5 million capital raise to fast-track clinical validation and commercialization of its ovarian cancer screening test and advance its CAR-exosome therapeutic program targeting solid tumors.

INOVIQ Limited has raised $11.5 million through a $9.5 million placement and a $2 million share purchase plan to accelerate the development and commercialisation of its EXO-OC ovarian cancer test and exosome therapeutic program.

Catapult Sports Ltd has announced a strategic acquisition of German soccer analytics firm Impect GmbH, funded by a fully underwritten A$130 million placement and a share purchase plan. This move enhances Catapult’s platform with advanced scouting and tactical insights, positioning the company for accelerated growth.

Catapult Sports is set to acquire German soccer analytics innovator IMPECT, backed by a A$150 million equity raise, enhancing its global sports technology platform with proprietary scouting insights.

Core Lithium has significantly increased its Ore Reserves at the Finniss Lithium Project by 42%, secured $54.3 million in fresh capital, and cleared all offtake obligations to advance its restart plans.

Nimy Resources reminds shareholders of the imminent closing of its Share Purchase Plan, following promising developments at its Mons Critical Mineral project and a recent $1.72 million placement.

Buru Energy secured key government approvals and identified a promising new gas prospect beneath its Rafael field, while raising $4.4 million to fund development activities. The company is gearing up for a Final Investment Decision in 3Q 2026, aiming for first material cash flow by 2028.

Prescient Therapeutics has bolstered its cash reserves to $12.3 million following a $9.8 million capital raise, while progressing its PTX-100 cancer therapy through global Phase 2 trials with encouraging early lymphoma results.

Arafura Rare Earths has successfully raised $9.83 million through an upsized Share Purchase Plan, well above its $5 million target, boosting total capital raised this year to nearly $90 million.